(Q48037129)

7 February 2018

title

Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. (English)

1 reference

7 February 2018

0 references

0 references

0 references

Lucas R

1

1 reference

7 February 2018

Juillard P

2

1 reference

7 February 2018

Decoster E

3

1 reference

7 February 2018

Redard M

4

1 reference

7 February 2018

Burger D

5

1 reference

7 February 2018

Donati Y

6

1 reference

7 February 2018

Giroud C

7

1 reference

7 February 2018

Monso-Hinard C

8

1 reference

7 February 2018

De Kesel T

9

1 reference

7 February 2018

Buurman WA

10

1 reference

7 February 2018

Moore MW

11

1 reference

7 February 2018

Dayer JM

12

1 reference

7 February 2018

Fiers W

13

1 reference

7 February 2018

Bluethmann H

14

1 reference

7 February 2018

Grau GE

15

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 July 1997

1 reference

7 February 2018

European Journal of Immunology

published in

1 reference

7 February 2018

volume

27

1 reference

7 February 2018

page(s)

1719-1725

1 reference

7 February 2018

issue

7

1 reference

7 February 2018

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Tumor necrosis factor and disease severity in children with falciparum malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Late treatment with anti-LFA-1 (CD11a) antibody prevents cerebral malaria in a mouse model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Cerebral malaria: mediators, mechanical obstruction or more?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Brain microvascular endothelial cells and leukocytes derived from patients with multiple sclerosis exhibit increased adhesion capacity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830270719

7 January 2021

Identifiers

DOI

10.1002/EJI.1830270719

1 reference

7 February 2018

release_2qq6fc2inveqphdho7fu2vcmnm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2qq6fc2inveqphdho7fu2vcmnm

24 November 2022

mapped directly with Wikidata item

PubMed ID

9247583

1 reference

7 February 2018